Tags |
|
|
Links |
|
|
Digg It - Six Steps to Effective Meetings
Most people in medium and large businesses, government, non-profits and other organizations spend the majority of their time in meetings. As managers and executives, their most valuable resource is their time and that of their people.
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
And yet more time is wasted in unproductive meetings than all other activities combined. Making meetings more productive is one of the most important thinks and any business or other organization can do. There are six key steps to
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
aking meetings more effective.
People. Insure that the right people are at the meeting. That they are there on time and that they focus on the meeting rather than taking cell phone calls and doing their e-mail. As much as people co
People. Insure that the right people are at the meeting. That they are there on time and that they focus on the meeting rather than taking cell phone calls and doing their e-mail. As much as people co
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
plain about meetings, people hate to feel they are missing something important. They feel excluded. It is critical that only the people who need to be at meetings attend them. Presenters who are not key participants should attend me
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
tings only to give their presentations.
Purpose. While most meetings have a purpose, that purpose must be clearly stated in the meeting invitation and again at the beginning of the meeting. Someone should be designated to keep the m
Purpose. While most meetings have a purpose, that purpose must be clearly stated in the meeting invitation and again at the beginning of the meeting. Someone should be designated to keep the m
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
eting focused on that purpose. Any issues that arise that are not tied to the purpose should be noted and captured for another appropriate meeting. Also, at the end of the meeting, the purpose of the meeting should be stated again pr
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
or to the attendees leaving. Invitation – Opening – Stay on Topic – Closing.
Meeting type. Within the purpose, there are three types of meetings. Meetings must to be limited to information, decision making or idea floating. Inform
Meeting type. Within the purpose, there are three types of meetings. Meetings must to be limited to information, decision making or idea floating. Inform
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
tional meetings are those where people present new information to the group. These meetings need to leave time for questions. Decision making meetings are those where issues have been previously raised, recommended courses of action
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
resented and decisions must be made by the body. The decisions must be documented. The final type of meeting is what we call an “idea floating” session. At these meetings, a pertinent issue or issues are raised and the people attend
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ng the meeting provide recommendations to address the issue or issues. These are then documented with owners to take the recommendations the next step.
Time. No meeting should last longer than one hour. Period. Meetings that last l
Time. No meeting should last longer than one hour. Period. Meetings that last l
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
nger than an hour are not productive, they lose focus, they take on additional topics and purposes and they become forums for grand standing. People should arrive at the meeting on time. The meeting should start on time. There should
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
be no more than five minutes to review the purpose of the meeting, who is attending and their role in the meeting plus the agenda for the meeting, which should have been distributed in advance. The meeting should cover the entire age
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
da in the next fifty minutes. The final five minutes should be used to recap the decisions, who will distribute the notes from the meeting and when the next meeting is scheduled. The meeting should end within the hour and not over.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
t is ideal to keep the meeting to 55 minutes including the opening and closing comments so people can be on time for their next meeting (on the hour) and are not distracted.
Document. Someone should be charged with documenting the pu
Document. Someone should be charged with documenting the pu
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
pose of the meeting, who attended it, the decisions made, any open issues and who owns action on them and when the next meeting will be held. Anything else in the notes is excessive. The notes should be distributed electronically wit
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
in twenty-four hours only to the attendees. There is a habit of forward meeting minutes to the world – up and down the chain of command. This serves little purpose and bogs down future meetings and creates excessive and unproductive
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ork for all involved.
Follow-up. It is up to the meeting lead (or chair) to insure that all items decided at the meeting including the open issues are either closed or a recommendation made by the owners of the issues. Often, issues
Follow-up. It is up to the meeting lead (or chair) to insure that all items decided at the meeting including the open issues are either closed or a recommendation made by the owners of the issues. Often, issues
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
remain open for months if not years. It is up to the owner of each issue to do whatever is required to bring them to closure or recommended next (action) step.
Considering that meetings take the majority of managers’ and executives’
Considering that meetings take the majority of managers’ and executives’
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ime during any given day, it is essential for them to take steps to make meetings more productive. By focusing on the critical elements of effective meetings, this can be done immediately. The key elements include: the right people,
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
clear purpose, a limited amount of time (and on time), documenting decisions and owners and follow-up. These simple but seldom followed steps will make any organization more effective and improve job satisfaction for the participants
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/47240/diggit-Six-Steps-to-Effective-Meetings.html">Six Steps to Effective Meetings</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/47240/diggit-Six-Steps-to-Effective-Meetings.html]Six Steps to Effective Meetings[/url]
Related Articles:
Are You Brand Worthy? Are You Brand Worthy?
Five Tips On Drawing Numbering System For Civil Engineer
Protocol For Unfriendly Co-Workers
Bookmark it:
|